What is the association between the child opportunity index and sleep apnea?
Best insight from top research papers
The Child Opportunity Index (COI) is associated with sleep health. Regional prevalence of insufficient sleep is linearly associated with the COI, which is an important predictor of health and economic outcomes . Sleep health is more strongly associated with overall COI and all its components than any other regional health metric . However, there is no direct mention of an association between the COI and sleep apnea in the provided abstracts.
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
31 Citations | The provided paper does not mention anything about the association between the child opportunity index and sleep apnea. |
2 Citations | The provided paper does not mention anything about the association between the child opportunity index and sleep apnea. |
| The provided paper does not mention anything about the association between the Child Opportunity Index and sleep apnea. | |
3 Citations | The provided paper does not mention anything about the association between the child opportunity index and sleep apnea. The paper focuses on evaluating if cardiopulmonary coupling calculated sleep quality may have a role in identifying children that may benefit from interventions for obstructive sleep apnea. |
| The provided paper does not mention anything about the association between the Child Opportunity Index and sleep apnea. |
Related Questions
What is the relationship between OSA (Obstructive Sleep Apnea) and cigarette smoking?5 answersCigarette smoking has a significant association with obstructive sleep apnea (OSA). Studies have shown that smoking contributes to the risk and severity of OSA. Nicotine in cigarettes affects sleep architecture, leading to disruptions in sleep quality and neuromuscular function, which can exacerbate OSA symptoms. Current smokers and ex-smokers have higher odds of OSA compared to non-smokers, with a dose-response relationship observed in some studies. Dual users of e-cigarettes and conventional cigarettes exhibit the highest prevalence of OSA, emphasizing the detrimental impact of smoking on sleep-disordered breathing. Smoking cessation may help manage OSA by potentially reducing upper airway inflammation, although more research is needed to fully understand the effects of quitting smoking on OSA severity.
What are cpap benefits in sleep apnea syndrome?5 answersContinuous Positive Airway Pressure (CPAP) therapy offers significant benefits in sleep apnea syndrome. Research indicates that CPAP can reduce cardiovascular risk in patients with coronary artery disease and obstructive sleep apnea, especially in those with an elevated pulse rate response to respiratory events. Additionally, CPAP treatment improves sleep quality by reducing apnea-induced awakenings and enhancing features of sleep architecture like slow oscillation and spindle EEG activity, ultimately promoting better sleep depth and neuronal homeostasis. Moreover, a novel simple CPAP device without pressure control has been developed, showing effectiveness in treating most patients with obstructive sleep apnea, potentially widening access to CPAP therapy in low-income countries due to its affordability. These findings collectively highlight CPAP's role in mitigating health risks associated with sleep apnea and improving overall sleep quality.
What data exist on sleep apnea and COPD?5 answersThe impact of obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) overlap syndrome (OVS) on sleep quality and cardiovascular outcomes has been explored in several studies. Patients with OVS have more severe hypoxia, lower sleep efficiency, and a higher prevalence of arterial hypertension, ischemic heart disease, and heart failure compared to patients with OSA alone. Nocturnal hypoxia is strongly associated with comorbidities, with mean nocturnal oxygen saturation (SpO2) and time below SpO2 of 90% (T90) being associated with increased odds of systemic hypertension, diabetes, and heart failure. Patients with OVS also have worse patient-reported outcomes, including fatigue, sleepiness, anxiety, depression, insomnia, and impaired function, compared to patients with COPD alone. Overall, the data suggest that OVS is associated with more sleep-related hypoxia, decreased sleep quality, and a higher risk for cardiovascular comorbidities compared to OSA or COPD alone.
What are common comorbidities for sleep apnea?5 answersCommon comorbidities for sleep apnea include anxiety, depression, hypertension, dyslipidemia, asthma, cardiovascular complications (arterial hypertension, pulmonary hypertension, chronic heart failure, arrhythmias, myocardial infarction), cerebrovascular complications (strokes), metabolic complications (insulin resistance, obesity, diabetes mellitus, metabolic syndrome), gastrointestinal complications (non-alcoholic liver disease), urinary complications (chronic renal failure), neuropsychiatric complications, and a wide range of malignancies.
Do you think there have been clinical correlation between sleep apnea and COPD?4 answersThere is a clinical correlation between sleep apnea and COPD. Patients with COPD alone and those with COPD and obstructive sleep apnea (OSA) both experience poor sleep quality, with no significant difference between the two groups in terms of sleep quality scores. Polysomnography results show changes in sleep patterns and reduced sleep efficiency in patients with COPD and OSA. Poor sleep quality in COPD patients is associated with severe COPD and poor health status, negatively impacting overall quality of life. Patients with OSA-COPD overlap syndrome (OVS) have lower sleep quality compared to those with OSA alone, and this is associated with decreased forced expiratory volume and arterial oxygen tension. OVS patients also have a higher risk of cardiovascular comorbidities, such as hypertension, ischemic heart disease, and heart failure.
How obesity make people have obstructive sleep apnea?5 answersObesity is strongly associated with obstructive sleep apnea (OSA). OSA is a sleep disorder characterized by recurrent episodes of upper airway collapse during sleep, leading to fragmented sleep and decreased oxygen levels. The prevalence of OSA is higher in individuals with obesity, with rates as high as 30%. The pathophysiology of OSA in obesity is complex and multifactorial, involving factors such as increased adipose tissue in the upper airway, altered respiratory mechanics, and inflammation. Obesity-related adipokines, such as leptin, adiponectin, and resistin, may also play a role in the development and severity of OSA. The exact mechanisms by which obesity contributes to OSA are still being studied, but it is clear that obesity is a significant risk factor for the development and progression of OSA.